AVAHMEDIUM SIGNALFINANCIAL10-K

AVAH reported solid revenue growth of 20% alongside substantially higher operating profitability, while expanding its acquisition team and completing another strategic transaction.

The company's operating leverage is clearly evident as revenue growth translated into meaningfully expanded operating margins, suggesting effective cost management and scaling benefits. The expansion of the acquisition team from five to eight people, combined with completing their eighteenth acquisition since 2017, indicates continued focus on inorganic growth strategy.

Comparing 2026-03-19 vs 2025-03-13View on EDGAR →
FINANCIAL ANALYSIS

AVAH delivered strong financial performance with revenue growing 20% to $2.4B and gross profit expanding 28% to $810.5M, demonstrating solid operational execution. Operating income grew substantially, reflecting improved operational efficiency and the benefits of scale. The balance sheet strengthened meaningfully with total assets reaching $2.0B and current assets increasing 43%, while accounts receivable growth of 18% remained proportional to the revenue expansion, suggesting healthy cash conversion dynamics.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
+83.5%
$139.8M$256.5M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Current Assets
Balance Sheet
+42.7%
$392.7M$560.2M

Current assets grew 42.7% — improving short-term liquidity or inventory/receivables build.

Gross Profit
P&L
+27.5%
$635.5M$810.5M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Total Assets
Balance Sheet
+21%
$1.7B$2.0B

Asset base grew 21% — expansion through organic growth, acquisitions, or capital deployment.

Revenue
P&L
+20.2%
$2.0B$2.4B

Revenue growing 20.2% — solid top-line momentum, watch margins for quality of growth.

Accounts Receivable
Balance Sheet
+18.2%
$265.2M$313.4M

Receivables grew 18.2% — monitor days sales outstanding for collection efficiency.

LANGUAGE CHANGES
NEW — 2026-03-19
PRIOR — 2025-03-13
ADDED
As of March 13, 2026, the registrant had 217,510,046 shares of common stock, $0.01 par value per share, outstanding.
The 2026 Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant's fiscal year ended January 3, 2026 .
Our Acquisition Team and Integration Management Office ( IMO ) We have a proven team of eight people dedicated to sourcing, evaluating and executing on all aspects of our acquisition strategy, as well as transformational initiatives.
Scale Advantages Result in a Network Effect, Accelerating Growth 7 We believe our scale enables a virtuous cycle of network effects and competitive advantages for our business.
Since 2017, we have completed and integrated eighteen acquisitions.
+7 more — sign up free →
REMOVED
As of March 7, 2025, the registrant had 195,093,866 shares of common stock, $0.01 par value per share, outstanding.
The 2025 Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant's fiscal year ended December 28, 2024 .
Our Acquisition Team and Integration Management Office (IMO) We have a proven team of five people dedicated to sourcing, evaluating and executing on all aspects of our acquisition strategy, as well as transformational initiatives.
Scale Advantages Result in a Network Effect, Accelerating Growth 7 Our scale enables a virtuous cycle of network effects and competitive advantages to our business.
These agreements apply to each of our three key businesses: Private Duty Services, Home Health and Hospice, and Medical Solutions.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →